Concepts (270)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Citrulline | 8 | 2021 | 108 | 2.650 |
Why?
|
| Lactation | 9 | 2020 | 210 | 2.520 |
Why?
|
| Milk, Human | 9 | 2022 | 277 | 2.350 |
Why?
|
| Arginine | 7 | 2021 | 500 | 2.280 |
Why?
|
| Mammary Glands, Human | 4 | 2015 | 184 | 1.420 |
Why?
|
| Arginase | 2 | 2020 | 48 | 0.910 |
Why?
|
| Galactose | 2 | 2015 | 87 | 0.890 |
Why?
|
| Hydrolases | 2 | 2021 | 123 | 0.780 |
Why?
|
| Duodenum | 1 | 2020 | 149 | 0.710 |
Why?
|
| Jejunum | 1 | 2020 | 216 | 0.700 |
Why?
|
| Glutamine | 2 | 2018 | 299 | 0.690 |
Why?
|
| Gluconeogenesis | 3 | 2015 | 121 | 0.650 |
Why?
|
| Glucose | 5 | 2015 | 1248 | 0.650 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2020 | 703 | 0.640 |
Why?
|
| Swine | 7 | 2021 | 1541 | 0.640 |
Why?
|
| Nutrigenomics | 1 | 2017 | 11 | 0.630 |
Why?
|
| Polyethylene Glycols | 2 | 2021 | 615 | 0.620 |
Why?
|
| Amino Acids | 1 | 2020 | 728 | 0.610 |
Why?
|
| Glycerol | 2 | 2015 | 99 | 0.600 |
Why?
|
| Lactose | 2 | 2020 | 63 | 0.560 |
Why?
|
| Gastrointestinal Tract | 1 | 2018 | 324 | 0.530 |
Why?
|
| Lipogenesis | 2 | 2021 | 76 | 0.520 |
Why?
|
| Lipids | 3 | 2013 | 644 | 0.500 |
Why?
|
| Intestinal Mucosa | 1 | 2020 | 1081 | 0.490 |
Why?
|
| Blood Glucose | 4 | 2015 | 1244 | 0.490 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2020 | 1498 | 0.490 |
Why?
|
| Triglycerides | 3 | 2019 | 603 | 0.460 |
Why?
|
| Lipid Metabolism | 2 | 2020 | 483 | 0.440 |
Why?
|
| Dietary Carbohydrates | 2 | 2014 | 134 | 0.440 |
Why?
|
| Uridine Diphosphate Galactose | 1 | 2012 | 6 | 0.440 |
Why?
|
| Metabolic Networks and Pathways | 3 | 2018 | 336 | 0.430 |
Why?
|
| Fasting | 2 | 2014 | 349 | 0.410 |
Why?
|
| Oligosaccharides | 2 | 2022 | 110 | 0.390 |
Why?
|
| Aging | 1 | 2019 | 1582 | 0.390 |
Why?
|
| Diabetes, Gestational | 1 | 2012 | 104 | 0.380 |
Why?
|
| Dietary Sucrose | 1 | 2010 | 42 | 0.380 |
Why?
|
| Breast Feeding | 3 | 2020 | 239 | 0.370 |
Why?
|
| Insulin | 3 | 2010 | 1454 | 0.360 |
Why?
|
| Vitamin B 12 | 2 | 2007 | 73 | 0.360 |
Why?
|
| Caloric Restriction | 1 | 2009 | 88 | 0.330 |
Why?
|
| Cholestasis | 2 | 2021 | 203 | 0.320 |
Why?
|
| Hymenolepiasis | 1 | 2007 | 1 | 0.320 |
Why?
|
| Hymenolepis nana | 1 | 2007 | 1 | 0.320 |
Why?
|
| Folic Acid | 2 | 2007 | 349 | 0.310 |
Why?
|
| Nutritional Status | 2 | 2020 | 337 | 0.300 |
Why?
|
| Epithelial Cells | 2 | 2020 | 1818 | 0.300 |
Why?
|
| Dietary Fats | 1 | 2009 | 339 | 0.300 |
Why?
|
| Lactobacillus acidophilus | 1 | 2006 | 1 | 0.300 |
Why?
|
| Methylmalonic Acid | 1 | 2006 | 15 | 0.300 |
Why?
|
| Intestinal Absorption | 1 | 2007 | 211 | 0.290 |
Why?
|
| Animals, Newborn | 3 | 2020 | 1338 | 0.290 |
Why?
|
| Female | 26 | 2021 | 141928 | 0.280 |
Why?
|
| MicroRNAs | 2 | 2017 | 2947 | 0.280 |
Why?
|
| Homocysteine | 1 | 2006 | 138 | 0.280 |
Why?
|
| Probiotics | 2 | 2020 | 228 | 0.270 |
Why?
|
| Neuroblastoma | 2 | 2022 | 686 | 0.270 |
Why?
|
| Animals | 19 | 2022 | 59536 | 0.270 |
Why?
|
| Social Class | 1 | 2007 | 310 | 0.270 |
Why?
|
| Growth Disorders | 1 | 2007 | 218 | 0.270 |
Why?
|
| Gene Expression Regulation | 3 | 2014 | 4053 | 0.270 |
Why?
|
| Fatty Acids | 2 | 2022 | 448 | 0.270 |
Why?
|
| Weight Loss | 1 | 2009 | 627 | 0.250 |
Why?
|
| N-Myc Proto-Oncogene Protein | 2 | 2022 | 82 | 0.250 |
Why?
|
| Infusions, Intravenous | 2 | 2018 | 1382 | 0.240 |
Why?
|
| Parenteral Nutrition | 3 | 2021 | 207 | 0.230 |
Why?
|
| Population Surveillance | 1 | 2007 | 627 | 0.230 |
Why?
|
| Carbon Isotopes | 2 | 2015 | 333 | 0.230 |
Why?
|
| Biological Availability | 2 | 2021 | 214 | 0.230 |
Why?
|
| Kinetics | 2 | 2021 | 2049 | 0.220 |
Why?
|
| Obesity | 2 | 2015 | 2884 | 0.210 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2012 | 1362 | 0.210 |
Why?
|
| Glycomics | 1 | 2021 | 27 | 0.200 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2021 | 29 | 0.200 |
Why?
|
| Biosynthetic Pathways | 1 | 2021 | 46 | 0.200 |
Why?
|
| Phytosterols | 1 | 2021 | 31 | 0.200 |
Why?
|
| Propane | 1 | 2020 | 31 | 0.190 |
Why?
|
| Glyceraldehyde | 1 | 2020 | 32 | 0.190 |
Why?
|
| Male | 15 | 2021 | 123000 | 0.190 |
Why?
|
| Urea Cycle Disorders, Inborn | 2 | 2020 | 80 | 0.190 |
Why?
|
| Liver Glycogen | 1 | 2020 | 31 | 0.180 |
Why?
|
| Polysaccharides | 1 | 2021 | 197 | 0.180 |
Why?
|
| Kidney | 2 | 2019 | 2146 | 0.180 |
Why?
|
| Argininosuccinate Lyase | 1 | 2020 | 66 | 0.180 |
Why?
|
| Metagenome | 1 | 2020 | 176 | 0.180 |
Why?
|
| Synbiotics | 1 | 2019 | 9 | 0.170 |
Why?
|
| Tissue Distribution | 1 | 2021 | 875 | 0.170 |
Why?
|
| Nitrogen Isotopes | 1 | 2018 | 60 | 0.170 |
Why?
|
| Ornithine Carbamoyltransferase | 1 | 2018 | 22 | 0.170 |
Why?
|
| Docosahexaenoic Acids | 1 | 2019 | 79 | 0.160 |
Why?
|
| Diet | 3 | 2020 | 1440 | 0.160 |
Why?
|
| Dipeptides | 1 | 2018 | 91 | 0.160 |
Why?
|
| Liver Diseases, Alcoholic | 1 | 2019 | 56 | 0.160 |
Why?
|
| Mice, Inbred C57BL | 5 | 2020 | 6942 | 0.160 |
Why?
|
| Endotoxins | 1 | 2018 | 96 | 0.160 |
Why?
|
| Bile Acids and Salts | 1 | 2020 | 246 | 0.160 |
Why?
|
| Intestinal Diseases | 1 | 2019 | 121 | 0.150 |
Why?
|
| Helicobacter pylori | 1 | 2007 | 1295 | 0.150 |
Why?
|
| Adult | 10 | 2017 | 77950 | 0.150 |
Why?
|
| Helicobacter Infections | 1 | 2007 | 1216 | 0.150 |
Why?
|
| Egypt | 2 | 2007 | 42 | 0.150 |
Why?
|
| Oxidation-Reduction | 2 | 2009 | 717 | 0.150 |
Why?
|
| Phenylbutyrates | 1 | 2017 | 59 | 0.150 |
Why?
|
| Microbiota | 2 | 2020 | 547 | 0.150 |
Why?
|
| Growth | 1 | 2017 | 117 | 0.150 |
Why?
|
| Insulin Resistance | 2 | 2015 | 731 | 0.150 |
Why?
|
| Ethanol | 1 | 2019 | 264 | 0.150 |
Why?
|
| Benzoates | 1 | 2017 | 136 | 0.140 |
Why?
|
| Nutritional Requirements | 1 | 2017 | 185 | 0.140 |
Why?
|
| Biological Transport | 2 | 2021 | 597 | 0.140 |
Why?
|
| Enteral Nutrition | 1 | 2018 | 316 | 0.140 |
Why?
|
| Lactic Acid | 2 | 2015 | 305 | 0.140 |
Why?
|
| Humans | 24 | 2022 | 261506 | 0.140 |
Why?
|
| Models, Animal | 1 | 2018 | 664 | 0.140 |
Why?
|
| Gene Expression Profiling | 4 | 2017 | 5159 | 0.140 |
Why?
|
| Reactive Oxygen Species | 1 | 2020 | 987 | 0.130 |
Why?
|
| Sodium Acetate | 1 | 2015 | 2 | 0.130 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2015 | 52 | 0.130 |
Why?
|
| Mice, Knockout | 3 | 2020 | 5710 | 0.130 |
Why?
|
| Premature Birth | 1 | 2020 | 407 | 0.130 |
Why?
|
| Cross-Over Studies | 2 | 2020 | 460 | 0.130 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2015 | 69 | 0.130 |
Why?
|
| Transcriptome | 2 | 2014 | 1859 | 0.130 |
Why?
|
| Isotope Labeling | 2 | 2018 | 142 | 0.130 |
Why?
|
| Liver Diseases | 1 | 2020 | 574 | 0.120 |
Why?
|
| Sex Characteristics | 1 | 2017 | 417 | 0.120 |
Why?
|
| Nitric Oxide | 1 | 2018 | 644 | 0.120 |
Why?
|
| Pyruvate Kinase | 1 | 2014 | 36 | 0.120 |
Why?
|
| Genes, Lethal | 1 | 2014 | 120 | 0.120 |
Why?
|
| Infant, Premature | 1 | 2019 | 787 | 0.120 |
Why?
|
| Intestines | 1 | 2018 | 686 | 0.120 |
Why?
|
| Fatty Liver | 1 | 2015 | 235 | 0.120 |
Why?
|
| Blood Chemical Analysis | 1 | 2014 | 118 | 0.110 |
Why?
|
| Pulmonary Alveoli | 1 | 2014 | 208 | 0.110 |
Why?
|
| Persistent Fetal Circulation Syndrome | 1 | 2014 | 92 | 0.110 |
Why?
|
| Genotype | 1 | 2020 | 4109 | 0.110 |
Why?
|
| Metabolism | 1 | 2012 | 55 | 0.110 |
Why?
|
| Pulmonary Veins | 1 | 2014 | 174 | 0.110 |
Why?
|
| Diet, High-Fat | 1 | 2014 | 241 | 0.110 |
Why?
|
| Pregnancy | 3 | 2019 | 7573 | 0.100 |
Why?
|
| Mice | 7 | 2021 | 34495 | 0.100 |
Why?
|
| Eating | 1 | 2014 | 421 | 0.100 |
Why?
|
| Protein Carbonylation | 1 | 2010 | 7 | 0.100 |
Why?
|
| Microarray Analysis | 1 | 2012 | 392 | 0.100 |
Why?
|
| Hormones | 1 | 2012 | 266 | 0.100 |
Why?
|
| Palmitic Acid | 1 | 2010 | 42 | 0.100 |
Why?
|
| Anti-Obesity Agents | 1 | 2010 | 30 | 0.100 |
Why?
|
| Infant | 4 | 2022 | 13310 | 0.100 |
Why?
|
| Estradiol | 1 | 2014 | 748 | 0.090 |
Why?
|
| Emulsions | 2 | 2021 | 82 | 0.090 |
Why?
|
| Lipid Peroxidation | 1 | 2010 | 157 | 0.090 |
Why?
|
| Soybean Oil | 2 | 2021 | 66 | 0.090 |
Why?
|
| Research Design | 1 | 2017 | 1544 | 0.090 |
Why?
|
| Stromal Cells | 1 | 2014 | 825 | 0.090 |
Why?
|
| Hexoses | 1 | 2009 | 11 | 0.090 |
Why?
|
| Fish Oils | 2 | 2021 | 88 | 0.090 |
Why?
|
| Ketone Bodies | 1 | 2009 | 56 | 0.090 |
Why?
|
| Single-Blind Method | 1 | 2010 | 409 | 0.090 |
Why?
|
| Calorimetry, Indirect | 1 | 2009 | 60 | 0.090 |
Why?
|
| Prevalence | 2 | 2007 | 3260 | 0.090 |
Why?
|
| Lactates | 1 | 2009 | 112 | 0.090 |
Why?
|
| Forkhead Transcription Factors | 1 | 2014 | 778 | 0.090 |
Why?
|
| C-Peptide | 1 | 2009 | 107 | 0.090 |
Why?
|
| Glucagon | 1 | 2009 | 196 | 0.090 |
Why?
|
| Estrogen Receptor alpha | 1 | 2014 | 701 | 0.090 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2009 | 159 | 0.080 |
Why?
|
| Diet, Reducing | 1 | 2009 | 87 | 0.080 |
Why?
|
| Lactulose | 1 | 2007 | 38 | 0.080 |
Why?
|
| Mannitol | 1 | 2007 | 54 | 0.080 |
Why?
|
| Permeability | 1 | 2007 | 167 | 0.080 |
Why?
|
| Dietary Proteins | 1 | 2009 | 241 | 0.080 |
Why?
|
| Yogurt | 1 | 2006 | 6 | 0.070 |
Why?
|
| Breath Tests | 1 | 2007 | 177 | 0.070 |
Why?
|
| Urea | 2 | 2018 | 290 | 0.070 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2006 | 53 | 0.070 |
Why?
|
| Young Adult | 2 | 2017 | 21445 | 0.070 |
Why?
|
| Body Height | 1 | 2007 | 231 | 0.070 |
Why?
|
| Energy Intake | 1 | 2009 | 515 | 0.070 |
Why?
|
| Nuclear Proteins | 1 | 2015 | 3343 | 0.060 |
Why?
|
| Texas | 1 | 2015 | 6311 | 0.060 |
Why?
|
| Chi-Square Distribution | 1 | 2006 | 1323 | 0.060 |
Why?
|
| Liver | 3 | 2019 | 2961 | 0.060 |
Why?
|
| Oxidative Stress | 2 | 2020 | 1129 | 0.060 |
Why?
|
| Models, Biological | 1 | 2012 | 3254 | 0.060 |
Why?
|
| Energy Metabolism | 1 | 2009 | 992 | 0.060 |
Why?
|
| Lung | 1 | 2014 | 3151 | 0.060 |
Why?
|
| Body Weight | 1 | 2007 | 1293 | 0.050 |
Why?
|
| Glycosyltransferases | 1 | 2022 | 34 | 0.050 |
Why?
|
| Dietary Supplements | 1 | 2006 | 558 | 0.050 |
Why?
|
| Child | 3 | 2007 | 29154 | 0.050 |
Why?
|
| Fucosyltransferases | 1 | 2021 | 76 | 0.050 |
Why?
|
| ARNTL Transcription Factors | 1 | 2021 | 57 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 2 | 2021 | 3101 | 0.050 |
Why?
|
| Transcription Factors | 1 | 2015 | 5270 | 0.050 |
Why?
|
| Glycosylation | 1 | 2021 | 213 | 0.050 |
Why?
|
| Sex Factors | 2 | 2017 | 2139 | 0.050 |
Why?
|
| Gangliosides | 1 | 2021 | 95 | 0.050 |
Why?
|
| Spores, Bacterial | 1 | 2020 | 49 | 0.050 |
Why?
|
| Fat Emulsions, Intravenous | 1 | 2021 | 70 | 0.050 |
Why?
|
| Gene Knockout Techniques | 1 | 2021 | 276 | 0.050 |
Why?
|
| Mucins | 1 | 2021 | 285 | 0.050 |
Why?
|
| Erythropoietin | 1 | 2021 | 205 | 0.050 |
Why?
|
| Olive Oil | 1 | 2019 | 21 | 0.040 |
Why?
|
| Adolescent | 2 | 2012 | 31252 | 0.040 |
Why?
|
| Fatty Liver, Alcoholic | 1 | 2019 | 5 | 0.040 |
Why?
|
| Tight Junction Proteins | 1 | 2019 | 13 | 0.040 |
Why?
|
| Fatty Acid Transport Proteins | 1 | 2019 | 12 | 0.040 |
Why?
|
| Alanine Transaminase | 1 | 2020 | 227 | 0.040 |
Why?
|
| Aldehydes | 1 | 2019 | 44 | 0.040 |
Why?
|
| Fermentation | 1 | 2019 | 60 | 0.040 |
Why?
|
| Fatty Acids, Volatile | 1 | 2019 | 52 | 0.040 |
Why?
|
| Gene Expression | 2 | 2019 | 3570 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2021 | 1053 | 0.040 |
Why?
|
| Ornithine Carbamoyltransferase Deficiency Disease | 1 | 2018 | 34 | 0.040 |
Why?
|
| Vasomotor System | 1 | 2018 | 29 | 0.040 |
Why?
|
| Mutation | 1 | 2018 | 15179 | 0.040 |
Why?
|
| Tissue Culture Techniques | 1 | 2018 | 114 | 0.040 |
Why?
|
| Argininosuccinate Synthase | 1 | 2018 | 54 | 0.040 |
Why?
|
| Mice, Inbred ICR | 1 | 2018 | 239 | 0.040 |
Why?
|
| Organoids | 1 | 2020 | 287 | 0.040 |
Why?
|
| Algorithms | 1 | 2009 | 3890 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2007 | 6100 | 0.040 |
Why?
|
| Dysbiosis | 1 | 2019 | 134 | 0.040 |
Why?
|
| Weaning | 1 | 2017 | 45 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2007 | 4314 | 0.040 |
Why?
|
| Nitrogen | 1 | 2017 | 162 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2020 | 1313 | 0.040 |
Why?
|
| Mice, Mutant Strains | 1 | 2018 | 634 | 0.040 |
Why?
|
| Healthy Volunteers | 1 | 2017 | 187 | 0.040 |
Why?
|
| Cell Line, Tumor | 2 | 2022 | 14551 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2020 | 7222 | 0.030 |
Why?
|
| Body Composition | 1 | 2019 | 595 | 0.030 |
Why?
|
| Benzamides | 1 | 2021 | 1832 | 0.030 |
Why?
|
| Random Allocation | 1 | 2017 | 703 | 0.030 |
Why?
|
| Diet, Western | 1 | 2015 | 23 | 0.030 |
Why?
|
| Carbohydrate Metabolism | 1 | 2015 | 74 | 0.030 |
Why?
|
| Feces | 1 | 2019 | 770 | 0.030 |
Why?
|
| Colon | 1 | 2019 | 670 | 0.030 |
Why?
|
| Cell Survival | 1 | 2021 | 3045 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 1945 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2020 | 1819 | 0.030 |
Why?
|
| Mitogens | 1 | 2014 | 75 | 0.030 |
Why?
|
| Infant, Newborn | 2 | 2019 | 8223 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2015 | 246 | 0.030 |
Why?
|
| Primary Cell Culture | 1 | 2014 | 208 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2019 | 1538 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2021 | 3821 | 0.030 |
Why?
|
| Oxygen Consumption | 1 | 2014 | 401 | 0.030 |
Why?
|
| Weight Gain | 1 | 2015 | 464 | 0.030 |
Why?
|
| Cellular Reprogramming | 1 | 2014 | 189 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2007 | 16273 | 0.020 |
Why?
|
| Heterozygote | 1 | 2014 | 1020 | 0.020 |
Why?
|
| Alternative Splicing | 1 | 2014 | 584 | 0.020 |
Why?
|
| Risk Factors | 1 | 2007 | 17523 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2015 | 769 | 0.020 |
Why?
|
| Endometrium | 1 | 2014 | 470 | 0.020 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2019 | 907 | 0.020 |
Why?
|
| Estrogens | 1 | 2014 | 751 | 0.020 |
Why?
|
| Biomarkers | 1 | 2021 | 5047 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2015 | 3536 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 3639 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 2992 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2015 | 4143 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2014 | 3154 | 0.020 |
Why?
|
| Brain | 1 | 2019 | 4113 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2006 | 32848 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2013 | 2291 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2014 | 7226 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 14289 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2014 | 11965 | 0.010 |
Why?
|
| Middle Aged | 1 | 2017 | 86204 | 0.010 |
Why?
|